Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Centers for Disease Control and Prevention 

          - [Program Announcement 00107] 

## A. Purpose 

The Centers for Disease Control and Prevention (CDC) announces the availability of fiscal year (FY) 2000 funds for a cooperative agreement program for Population-Based Surveillance of Autism Spectrum Disorders and other Developmental Disabilities. CDC is committed to achieving the health promotion and disease prevention objectives of “Healthy People 2010.” This announcement is related to the focus area of Maternal, Infant and Child Health. http://www.health.gov/​healthypeople. 

The purpose of the program is to: Enhance an existing system or develop and implement a new system to undertake a multiple source surveillance methodology, from existing data records, for determining the prevalence of autism and other developmental disabilities, such as mental retardation, cerebral palsy, and vision and hearing impairments, in 3-10 year-old children within a geographically-defined area (combination of States, Statewide, or regions within a State). 

## B. Eligible Applicants 

                    Assistance will be provided only to the health departments of States or their                           ( print page 25935)                        bona fide agents, including the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, federally recognized Indian tribal governments, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau.                 

Applicants must document a surveillance population of at least 30,000 live per births per year within a State, area of a state (such as the catchment of a local health agency), or a combination of States. 

# Note:

Only one application will be accepted from each State or combination of States, and the latter must specify which State is the lead applicant.

## C. Availability of Funds 

Approximately $300,000 is available in FY 2000 to fund two awards. Each award is expected to be approximately $150,000. It is expected that the awards will begin on or about September 30, 2000, and will be made for a 12-month budget period within a project period of five years. Funding estimates may change. 

Continuation awards within an approved project period will be made on the basis of satisfactory progress as evidenced by required reports and the availability of funds. 

## D. Program Requirements 

In conducting activities to achieve the purpose of this program, the recipient will be responsible for the activities under 1. (Recipient Activities), and CDC will be responsible for the activities listed under 2. (CDC Activities). 

### 1. Recipient Activities 

a. To develop or enhance a surveillance program for autism and other developmental disabilities: 

i. Develop surveillance case definition(s); 

ii. Develop multiple source surveillance methodology; and 

iii. Develop data collection instruments and methods for obtaining information from medical/clinical and school records. 

b. Establish a multiple-source methodology to ascertain cases of autism and generate population-based prevalence estimates by developing collaborative relationships with appropriate professionals and organizations. 

c. Develop a plan for training community service providers to improve case ascertainment. 

d. Implement quality assurance procedures, including clinical validation of diagnoses in a sample of cases, to ensure that study protocols are being followed. 

e. Develop an evaluation plan for estimating the completeness of the surveillance system. 

f. Compile and disseminate the findings of the project. 

### 2. CDC Activities 

a. Assist recipient in the development and implementation of surveillance activities including the development of a standardized surveillance case definition. 

b. Provide current scientific information on surveillance methods. 

c. Provide assistance in the development of an evaluation plan for the completeness of the surveillance system. 

## E. Application Content 

Use the information in the Program Requirements, Other Requirements, and Evaluation Criteria sections to develop the application content. Your application will be evaluated on the criteria listed, so it is important to follow them in laying out your program plan. The narrative should be no more than 25 double-spaced pages, printed on one side, with one inch margins, unreduced font, unbound, and unstapled. 

## F. Submission and Deadline 

### Application 

Submit the original and two copies of PHS 5161-1 (OMB Number 0937-0189). Forms are in the application kit. 

                    On or before July 7, 2000, submit the application to the Grants Management Specialist identified in the “Where to Obtain Additional Information” section of this announcement.                     *Deadline:*                     Applications shall be considered as meeting the deadline if they are either:                 

(a) Received on or before the deadline date; or 

(b) Sent on or before the deadline date and received in time for submission to the Objective Review Panel. (Applicants must request a legibly dated U.S. Postal Service postmark or obtain a legibly dated receipt from a commercial carrier or U.S. Postal Service. Private metered postmarks shall not be acceptable as proof of timely mailing.) 

*Late Applications:*                     Applications which do not meet the criteria in (a) or (b) above are considered late applications, will not be considered, and will be returned to the applicant.                 

## G. Evaluation Criteria 

Each application will be evaluated individually against the following criteria by an independent review group appointed by CDC. 

### 1. Understanding of the Problem (20 Percent) 

(a) The extent to which the applicant has a clear, concise understanding of the requirements, objectives, and purposes of the cooperative agreement. 

(b) The extent to which the application reflects an understanding of the complexities of autism and developmental disabilities surveillance. 

### 2. Technical Approach (30 Percent) 

The extent to which the applicant describes the planning process, including specific planning objectives, strategies for achieving these objectives, and describes an approach to surveillance of autism and other developmental disabilities. The applicant should demonstrate its collaboration with health and education services that would be appropriate sources of cases for the surveillance system (by letters of support). The degree to which the applicant has met the CDC policy requirements regarding the inclusion of women, ethnic, and racial groups in the proposed research. This includes: 

(a) The proposed plan for the inclusion of both sexes and racial and ethnic minority populations for appropriate representation. 

(b) The proposed justification when representation is limited or absent. 

(c) A statement as to whether the design of the study is adequate to measure differences when warranted. 

(d) A statement as to whether the plans for recruitment and outreach for study participants include the process of establishing partnerships with communities and recognition of mutual benefits. 

### 3. Capability and Experience (30 Percent) 

The extent to which the applicant has the professed skills and experience to conduct a project of this nature, including reputation in the field and demonstrated experience in conducting similar projects. 

### 4. Staffing and Management Resources (20 Percent) 

                    The extent to which the applicant demonstrates that the proposed Project Director or Principal Investigator is knowledgeable regarding autism, developmental disabilities, and surveillance issues, as evidenced by publications, presentations, or other materials that document prior work. The extent to which the applicant demonstrates that other project staff                           ( print page 25936)                        have appropriate training and experience in the field of autism, other developmental disabilities, and surveillance activities, as evidenced by publications, presentations, or other materials that document prior work. Demonstration of the ability to provide adequate facilities and other necessary resources to carry out all proposed activities.                 

### 5. Budget (Not Scored) 

The extent to which the budget is reasonable, clearly justified, and consistent with the stated objectives and proposed activities. 

### 6. Human Subjects Requirements (Not Scored) 

The extent to which the applicant complies with the Department of Health and Human Services regulation (45 CFR part 46) on the protection of human subjects. 

## H. Other Requirements 

### Technical Reporting Requirements 

Provide CDC with original plus two copies of:

1. Semi-annual reports, no more than 30 days after the end of the report period; 

2. Financial status report, no more than 90 days after the end of the budget period; and

3. Final financial status and performance reports, no more than 90 days after the end of the project period. Send all reports to the Grants Management Specialist identified in the “Where to Obtain Additional Information” section of this announcement. 

The following additional requirements are applicable to this program. For a complete description of each, see Attachment I in the application kit. 

AR-1 Human Subjects Requirements 

AR-2 Requirements for Inclusion of Women and Racial and Ethnic Minorities in Research 

AR-7 Executive Order 12372 Review 

AR-9 Paperwork Reduction Act Requirements 

AR-10 Smoke-Free Workplace Requirements 

AR-11 Healthy People 2010 

AR-12 Lobbying Restrictions 

## I. Authority and Catalog of Federal Domestic Assistance Number 

This program is authorized under sections 301 and 317 of the Public Health Service Act, [42 U.S.C. sections 241 and 247b, as amended]. The Catalog of Federal Domestic Assistance number is 93.283. 

## J. Where To Obtain Additional Information 

This and other documents may be downloaded through the CDC homepage on the Internet at http://www.cdc.gov (click on funding). 

Please refer to Program Announcement 00107 when you request information. For business management technical assistance, please contact: Mattie B. Jackson, Grants Management Specialist, Grants Management Branch, Procurement and Grants Office, Centers for Disease Control and Prevention, 2920 Brandywine Road, Room 3000, Atlanta, GA 30341-4146, Telephone number: 770/488-2718, Email address: mij3@cdc.gov.

For program technical assistance, contact: Tom Horne, Principal Management Officer, Developmental Disabilities Branch, National Center for Environmental Health, Centers for Disease Control and Prevention (F-15), 4770 Buford Hwy, NE, Atlanta, GA 30341, Telephone: 770/488-7364, Email address: tjh1@cdc.gov.

Dated: April 28, 2000. 

John L. Williams, 

Director, Procurement and Grants Office, Centers for Disease Control and Prevention (CDC). 

[FR Doc. 00-11092 Filed 5-3-00; 8:45 am] 

BILLING CODE 4163-18-P